|
1
|
Hauth JC, Ewell MG, Levine RJ, Esterlitz
JR, Sibai B, Curet LB, Catalano PM and Morris CD: Pregnancy
outcomes in healthy nulliparas who developed hypertension. Calcium
for preeclampsia prevention study group. Obstet Gynecol. 95:24–28.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chappell LC, Cluver CA, Kingdom J and Tong
S: Pre-eclampsia. Lancet. 398:341–354. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Barton JR and Sibai BM: Prediction and
prevention of recurrent preeclampsia. Obstet Gynecol. 112:359–372.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Karumanchi SA: Angiogenic factors in
preeclampsia: From diagnosis to therapy. Hypertension.
67:1072–1079. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shaw J, Tang Z, Schneider H, Salje K,
Hansson SR and Guller S: Inflammatory processes are specifically
enhanced in endothelial cells by placental-derived TNF-alpha:
Implications in preeclampsia (PE). Placenta. 43:1–8. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Harmon AC, Cornelius DC, Amaral LM,
Faulkner JL, Cunningham MW Jr, Wallace K and LaMarca B: The role of
inflammation in the pathology of preeclampsia. Clin Sci (Lond).
130:409–419. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cotechini T, Komisarenko M, Sperou A,
Macdonald-Goodfellow S, Adams MA and Graham CH: Inflammation in rat
pregnancy inhibits spiral artery remodeling leading to fetal growth
restriction and features of preeclampsia. J Exp Med. 211:165–179.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fan M, Li X, Gao X, Dong L, Xin G, Chen L,
Qiu J and Xu Y: LPS induces preeclampsia-like phenotype in rats and
HTR8/SVneo cells dysfunction through TLR4/p38 MAPK pathway. Front
Physiol. 10:10302019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kadam L, Kilburn B, Baczyk D, Kohan-Ghadr
HR, Kingdom J and Drewlo S: Rosiglitazone blocks first trimester
in-vitro placental injury caused by NF-κB-mediated inflammation.
Sci Rep. 9:20182019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zaga-Clavellina V, Garcia-Lopez G,
Flores-Herrera H, Espejel-Nuñez A, Flores-Pliego A,
Soriano-Becerril D, Maida-Claros R, Merchant-Larios H and
Vadillo-Ortega F: In vitro secretion profiles of interleukin
(IL)-1beta, IL-6, IL-8, IL-10, and TNF alpha after selective
infection with Escherichia coli in human fetal membranes. Reprod
Biol Endocrinol. 5:462007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Poston L: Endothelial dysfunction in
pre-eclampsia. Pharmacol Rep. 58 (Suppl 1):S69–S74. 2006.PubMed/NCBI
|
|
12
|
Black KD and Morin KH: Development and
testing of the preeclampsia prenatal symptom-monitoring checklist
(PPSMC). J Nurs Meas. 22:14–28. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Anderson CM and Schmella MJ: CE:
Preeclampsia: Current approaches to nursing management. Am J Nurs.
117:30–38. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xiong Z, Wang X, Jiang S, Jin M and Chen
W: Association between pentraxin-3 and the risk of preeclampsia: A
meta-analysis. Medicine (Baltimore). 99:e207442020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Napoleone E, di Santo A, Peri G, Mantovani
A, de Gaetano G, Donati MB and Lorenzet R: The long pentraxin PTX3
up-regulates tissue factor in activated monocytes: Another link
between inflammation and clotting activation. J Leukoc Biol.
76:203–209. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Akhter T, Wikstrom AK, Larsson M, Larsson
A, Wikstrom G and Naessen T: Serum Pentraxin 3 is associated with
signs of arterial alteration in women with preeclampsia. Int J
Cardiol. 241:417–422. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ovayolu A, Turksoy VA, Ovayolu G, Ozek MA,
Dogan I and Karaman E: Analyses of interleukin-6, presepsin and
pentraxin-3 in the diagnosis and severity of late-onset
preeclampsia. J Matern Fetal Neonatal Med. 35:299–307. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Turkmen O, Mollaoglu S, Goynumer G and
Isbilen B: Plasma pentraxin 3 levels in preeclamptic patients. Clin
Exp Obstet Gynecol. 42:220–223. 2015.PubMed/NCBI
|
|
19
|
Hamad RR, Eriksson MJ, Berg E, Larsson A
and Bremme K: Impaired endothelial function and elevated levels of
pentraxin 3 in early-onset preeclampsia. Acta Obstet Gynecol Scand.
91:50–56. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Popovici RM, Krause MS, Jauckus J,
Germeyer A, Brum IS, Garlanda C, Strowitzki T and von Wolff M: The
long pentraxin PTX3 in human endometrium: Regulation by steroids
and trophoblast products. Endocrinology. 149:1136–1143. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Abrahams VM: The role of the Nod-like
receptor family in trophoblast innate immune responses. J Reprod
Immunol. 88:112–117. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kaya B, Nayki U, Nayki C, Ulug P, Oner G,
Gultekin E and Yildirim Y: Proliferation of trophoblasts and Ki67
expression in preeclampsia. Arch Gynecol Obstet. 291:1041–1046.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fathipour V, Khaki Z and Nassiri SM:
Evaluation of matrix metalloproteinases (MMP)-2 and MMP-9 activity
in serum and biochemical and hematological parameters in
spontaneous canine cutaneous tumors before and after surgical
treatment. Vet Res Forum. 9:19–26. 2018.PubMed/NCBI
|
|
25
|
Li W, Mata KM, Mazzuca MQ and Khalil RA:
Altered matrix metalloproteinase-2 and −9 expression/activity links
placental ischemia and anti-angiogenic sFlt-1 to uteroplacental and
vascular remodeling and collagen deposition in hypertensive
pregnancy. Biochem Pharmacol. 89:370–385. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shimonovitz S, Hurwitz A, Dushnik M,
Anteby E, Geva-Eldar T and Yagel S: Developmental regulation of the
expression of 72 and 92 kd type IV collagenases in human
trophoblasts: A possible mechanism for control of trophoblast
invasion. Am J Obstet Gynecol. 171:832–838. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Prutsch N, Fock V, Haslinger P, Haider S,
Fiala C, Pollheimer J and Knöfler M: The role of interleukin-1β in
human trophoblast motility. Placenta. 33:696–703. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bonacina F, Moregola A, Porte R, Baragetti
A, Bonavita E, Salatin A, Grigore L, Pellegatta F, Molgora M,
Sironi M, et al: Pentraxin 3 deficiency protects from the metabolic
inflammation associated to diet-induced obesity. Cardiovasc Res.
115:1861–1872. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Muller B, Peri G, Doni A, Torri V,
Landmann R, Bottazzi B and Mantovani A: Circulating levels of the
long pentraxin PTX3 correlate with severity of infection in
critically ill patients. Crit Care Med. 29:1404–1407. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mauri T, Bellani G, Patroniti N, Coppadoro
A, Peri G, Cuccovillo I, Cugno M, Iapichino G, Gattinoni L, Pesenti
A and Mantovani A: Persisting high levels of plasma pentraxin 3
over the first days after severe sepsis and septic shock onset are
associated with mortality. Intensive Care Med. 36:621–629. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mauri T, Coppadoro A, Bellani G, Bombino
M, Patroniti N, Peri G, Mantovani A and Pesenti A: Pentraxin 3 in
acute respiratory distress syndrome: An early marker of severity.
Crit Care Med. 36:2302–2308. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huppertz B: The critical role of abnormal
trophoblast development in the etiology of preeclampsia. Curr Pharm
Biotechnol. 19:771–780. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Longtine MS, Chen B, Odibo AO, Zhong Y and
Nelson DM: Villous trophoblast apoptosis is elevated and restricted
to cytotrophoblasts in pregnancies complicated by preeclampsia,
IUGR, or preeclampsia with IUGR. Placenta. 33:352–359. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang X, Qi C and Lin J: Enhanced
expressions of matrix metalloproteinase (MMP)-2 and −9 and vascular
endothelial growth factors (VEGF) and increased microvascular
density in the endometrial hyperplasia of women with anovulatory
dysfunctional uterine bleeding. Fertil Steril. 93:2362–2367. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mishra B, Kizaki K, Koshi K, Ushizawa K,
Takahashi T, Hosoe M, Sato T, Ito A and Hashizume K: Expression of
extracellular matrix metalloproteinase inducer (EMMPRIN) and its
related extracellular matrix degrading enzymes in the endometrium
during estrous cycle and early gestation in cattle. Reprod Biol
Endocrinol. 8:602010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Su MT, Tsai PY, Tsai HL, Chen YC and Kuo
PL: MiR-346 and miR-582-3p-regulated EG-VEGF expression and
trophoblast invasion via matrix metalloproteinases 2 and 9.
Biofactors. 43:210–219. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Isaka K, Usuda S, Ito H, Sagawa Y,
Nakamura H, Nishi H, Suzuki Y, Li YF and Takayama M: Expression and
activity of matrix metalloproteinase 2 and 9 in human trophoblasts.
Placenta. 24:53–64. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kunes P, Holubcova Z, Kolackova M and
Krejsek J: Pentraxin 3(PTX 3): An endogenous modulator of the
inflammatory response. Mediators Inflamm. 2012:9205172012.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Equils O, Kellogg C, McGregor J, Gravett
M, Neal-Perry G and Gabay C: The role of the IL-1 system in
pregnancy and the use of IL-1 system markers to identify women at
risk for pregnancy complications†. Biol Reprod. 103:684–694. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Takamura S, Takahashi A, Inoue Y and
Teraki Y: Effects of tumor necrosis factor-alpha, interleukin-23
and interleukin-17A inhibitors on bodyweight and body mass index in
patients with psoriasis. J Dermatol. 45:1130–1134. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kocyigit Y, Atamer Y, Atamer A, Tuzcu A
and Akkus Z: Changes in serum levels of leptin, cytokines and
lipoprotein in pre-eclamptic and normotensive pregnant women.
Gynecol Endocrinol. 19:267–273. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Luppi P and Deloia JA: Monocytes of
preeclamptic women spontaneously synthesize pro-inflammatory
cytokines. Clin Immunol. 118:268–275. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Alanbay I, Coksuer H, Ercan CM, Ustun Y,
Pala G, Karasahin KE, Ozturk O, Kurt I and Baser I:
Chitotriosidase, interleukin-1 beta and tumor necrosis factor alpha
levels in mild preeclampsia. Arch Gynecol Obstet. 285:1505–1511.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hannum CH, Wilcox CJ, Arend WP, Joslin FG,
Dripps DJ, Heimdal PL, Armes LG, Sommer A, Eisenberg SP and
Thompson RC: Interleukin-1 receptor antagonist activity of a human
interleukin-1 inhibitor. Nature. 343:336–340. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Powers NE, Swartzwelter B, Marchetti C, de
Graaf DM, Lerchner A, Schlapschy M, Datar R, Binder U, Edwards CK
III, Skerra A and Dinarello CA: PASylation of IL-1 receptor
antagonist (IL-1Ra) retains IL-1 blockade and extends its duration
in mouse urate crystal-induced peritonitis. J Biol Chem.
295:868–882. 2020. View Article : Google Scholar : PubMed/NCBI
|
